2026-08-21 · By SEPT AI
U.S. equities delivered a split session on Friday, with blue-chip strength offset by technology weakness as investors digested a flurry of corporate filings and a notable shift in crypto demand. The Dow Jones Industrial Average managed a modest gain, while the tech-heavy Nasdaq retreated, leaving the broader S&P 500 virtually flat.
The Dow, tracked by the SPDR Dow Jones Industrial Average ETF (DIA), rose 0.41% to close at $532.19, recovering from an intraday low of $529.43 to touch a high of $532.91. The Russell 2000, via the iShares Russell 2000 ETF (IWM), eked out a 0.03% gain to finish at $299.94, barely budging from its open. In contrast, the Invesco QQQ Trust (QQQ) slipped 0.25% to $713.41, pressured by selling in large-cap growth names. The SPDR S&P 500 ETF (SPY) edged down 0.05% to $765.69, after swinging between $764.17 and $767.85.
The Fear & Greed Index settled at 72, firmly in "Greed" territory, suggesting investor sentiment remains buoyant despite the mixed tape.
The day's action was dominated by a wave of capital markets activity, particularly in the small-cap and biotech spaces. A cascade of shelf registrations and at-the-market equity offerings weighed on sentiment for many names, creating a bifurcated market where defensive, large-cap value stocks found buyers while speculative names struggled under the weight of potential dilution.
The session was defined by extreme moves, with several stocks swinging by more than 30%.
Leading the upside was SDOT, which surged 60.62% to $13.23 on heavy volume of over 18 million shares, though no specific catalyst was immediately apparent in the data. RFAI jumped 56.75% to $62.70, while USDE climbed 46.23% to $7.37 on massive volume of 78.4 million shares.
On the downside, SUGP cratered 58.49% to $1.59, and GDC tumbled 40.15% to $1.55. CDTG fell 29.59% to $1.19, and MI dropped 24.68% to $2.90.
The primary catalyst for many of the day's losers was dilution. A wave of filings hit the tape, including prospectuses from Alzamend Neuro (ALZN) for the resale of up to 98.4 million common shares, Tempest Therapeutics (TPST) for the sale of up to 8.9 million shares, and Nuvectis Pharma (NU) for up to $200 million in securities. Applied Optoelectronics (AAOI) shares fell after announcing a $600 million at-the-market equity offering through Raymond James and Needham & Company. Oruka Therapeutics (ORKA) filed for a $1 billion mixed shelf, while MAIA Biotechnology (MAIA) filed for $150 million. enVVeno Medical (NVNO) also filed to offer up to $100 million in securities.
Not all news was negative. Cytek Biosciences (CTKB) saw a positive legal catalyst after a jury found in its favor on three of four asserted patent claims, awarding $20 million in lost profits and $36 million in royalties. Real Brokerage (REAX) gained after the Supreme Court of British Columbia granted a final order for its arrangement with RE/MAX Holdings, with the transaction expected to close August 24. Two Harbors Investment (TWO) also rose after receiving final regulatory approval for its merger with CrossCountry Mortgage, expected to close August 25.
Key Earnings & Corporate News
La Rosa Holdings (LRHC) reported a second-quarter EPS of $(1.66), an improvement from $(77.00) a year ago, though sales fell to $15.052 million from $20.232 million. The stock was not among the top movers but the earnings miss weighed on sentiment.
loanDepot (LDI) received a non-compliance notice from the NYSE, a negative compliance risk catalyst.
Kairos Pharma (KAPA) announced a 1-for-7 reverse stock split, effective September 1, a move often viewed as a signal of distress.
Planet Green Holdings (PLAG) saw a positive dilution-related catalyst as its ATM sales agreement with Curvature Securities was terminated, with no shares sold under the program.
KNOREX (KNRX) announced its FY25 financial statement includes a going concern intention, a compliance risk flag.
No major economic data releases were highlighted in the day's news flow. The market's focus remained squarely on corporate filings and individual stock catalysts.
Insider buying activity was notably robust, signaling confidence from corporate executives in their own stocks.
- RSG saw the largest dollar volume, with 40 insiders buying a total of $465.5 million.
- MTN had two insiders buying $5.0 million.
- KKR saw one insider purchase $4.7 million.
- UBER had two insiders buying $1.6 million.
- HBAN saw 15 insiders buy $1.4 million.
- TSM had 77 insiders buying $1.2 million.
- TXT saw one insider buy $988,594.
- BA had two insiders buying $799,311.
- NVR saw one insider buy $73,694.
- WHR had one insider buy $198,829.
All of these stocks received a STRONG_BUY score of 3, indicating significant insider conviction.
In the cryptocurrency space, Bitcoin's recent rally is showing signs of maturation. According to a key news item, the rally is shifting from a short squeeze dynamic to genuine ETF demand, with inflows hitting $1.6 billion. This suggests institutional interest is broadening, providing a more sustainable foundation for the digital asset's price action.
Investors will be watching for any follow-through on the wave of equity offerings and shelf registrations, which could continue to pressure small-cap and biotech names. The merger calendar remains active, with the Real Brokerage/RE/MAX and Two Harbors/CrossCountry deals set to close next week. On the macro front, any Fed commentary or economic data releases will be closely scrutinized for clues on the interest rate path. The insider buying spree across large-cap names like RSG, KKR, and UBER may provide a floor for those stocks, offering a potential tailwind for the broader market.
Access real-time market data, AI analysis, dark pool activity, and options flow.
Start Free Trial